LRMR - Larimar Therapeutics, Inc.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 4.2

Open

$ 4.22

Bid

$ 4.04 x 100

Ask

$ 4.45 x 18

Day's Range

$ 4.07 - $ 4.30

52 Week Range

$ 1.61 - $ 9.50

Volume

1,276,155

Average Volume

Market Cap

359.48M

Beta (5Y Monthly)

$ 1.34

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2025	06-30-2025	10-Q
2	04-30-2025	03-31-2025	10-Q
3	03-24-2025	12-31-2024	10-K
4	10-30-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	03-14-2024	12-31-2023	10-K
8	11-14-2023	09-30-2023	10-Q
9	08-10-2023	06-30-2023	10-Q
10	05-15-2023	03-31-2023	10-Q
11	03-14-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-12-2022	03-31-2022	10-Q
15	03-25-2022	12-31-2021	10-K
16	11-12-2021	09-30-2021	10-Q
17	08-12-2021	06-30-2021	10-Q
18	05-10-2021	03-31-2021	10-Q
19	03-04-2021	12-31-2020	10-K
20	11-12-2020	09-30-2020	10-Q
21	08-14-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	03-05-2020	12-31-2019	10-K
24	11-06-2019	09-30-2019	10-Q
25	08-08-2019	06-30-2019	10-Q
26	05-09-2019	03-31-2019	10-Q
27	03-14-2019	12-31-2018	10-K
28	11-09-2018	09-30-2018	10-Q
29	08-09-2018	06-30-2018	10-Q
30	05-10-2018	03-31-2018	10-Q
31	03-09-2018	12-31-2017	10-K
32	11-07-2017	09-30-2017	10-Q
33	08-09-2017	06-30-2017	10-Q
34	05-09-2017	03-31-2017	10-Q
35	03-10-2017	12-31-2016	10-K
36	11-09-2016	09-30-2016	10-Q
37	08-05-2016	06-30-2016	10-Q
38	05-10-2016	03-31-2016	10-Q
39	03-15-2016	12-31-2015	10-K
40	11-13-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

quantum-computing-mesoblast-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

Quantum Computing, Mesoblast And Other Big...
10/06/2025 12:09:29

Oppenheimer Maintains Outperform on Larima...
10/02/2025 13:27:47

Oppenheimer analyst Andreas Argyrides maintains Larimar Therapeutics (NASDAQ:LRMR) with a Outperform and lowers the price ta...

12 Health Care Stocks Moving In Wednesday'...
10/01/2025 17:06:01

Wedbush Maintains Outperform on Larimar Th...
09/30/2025 12:47:35

Wedbush analyst Laura Chico maintains Larimar Therapeutics (NASDAQ:LRMR) with a Outperform and lowers the price target from ...

Baird Maintains Outperform on Larimar Ther...
09/30/2025 11:42:17

Baird analyst Joel Beatty maintains Larimar Therapeutics (NASDAQ:LRMR) with a Outperform and lowers the price target from $1...

12 Health Care Stocks Moving In Monday's I...
09/29/2025 17:06:50

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

larimar-therapeutics-stock-falls-after-patients-report-allergic-reaction-in-pivotal-study

Larimar Therapeutics Stock Falls After Pat...
09/29/2025 15:20:32

Larimar Therapeutics Inc. (NASDAQ: LRMR) is trading lower on Monday after the company released data from the ongoing long-term ...

12 Health Care Stocks Moving In Monday's P...
09/29/2025 12:09:33

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...

Market-Moving News for September 29th
09/29/2025 11:20:17

LRMR: -53% | Larimar shares are trading lower after the company reported seven patients experienced anaphylaxis and were withdr...

Larimar Says Seven OL Study Participants E...
09/29/2025 11:05:00

Larimar Therapeutics Announces Data From O...
09/29/2025 11:04:00

why-merus-shares-are-trading-higher-by-38-here-are-20-stocks-moving-premarket

Why Merus Shares Are Trading Higher By 38%...
09/29/2025 09:07:53

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus fo...

Reported Sunday, Larimar To Provide Nomlab...
09/29/2025 06:33:24

JMP Securities Reiterates Market Outperfor...
08/19/2025 12:52:36

JMP Securities analyst Jonathan Wolleben reiterates Larimar Therapeutics (NASDAQ:LRMR) with a Market Outperform and maintain...

JMP Securities Maintains Market Outperform...
08/15/2025 13:25:52

JMP Securities analyst Jonathan Wolleben maintains Larimar Therapeutics (NASDAQ:LRMR) with a Market Outperform and lowers th...

Larimar Therapeutics Q2 EPS $(0.41) Beats ...
08/14/2025 11:16:04

Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of ...

Reported Earlier, Larimar Therapeutics Pri...
07/30/2025 07:49:47

Larimar intends to use the net proceeds from the proposed offering to support the development of nomlabofusp and other pipeline...

12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 21:06:19

Larimar Therapeutics Announces Proposed Un...
07/29/2025 20:03:04

- Larimar Therapeutics, Inc. ("Larimar") (NASDAQ:LRMR), a clinical-stage biotechnology company focused on developing tr...

Larimar Highlights Data for Rare Disease D...
07/08/2025 11:09:06

Larimar Therapeutics, Inc. (Larimar) (NASDAQ:LRMR), a clinical-stage biotechnology company focused on developing treatments for...